Rezpegaldesleukin
nektar therapeutics,eli lilly
['derm', 'aldesleukin', 'psoriasis', 'atopic dermatitis ', 'nektar']
$nktr nektar therapeutics presents data for rezpegaldesleukin (ly3471851) in patients with atopic dermatitis and psoriasis from two separate clinical studies at 2022 european academy of dermatology (eadv) congress stock news alerts in bio
Over 500 members. DM us for our premium stock alerts.